Cargando…
Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions
In treatment or prevention of COVID-19, ivermectin is not approved by the United States (US) Food and Drug Administration (FDA). Nonetheless, in the US, prescriptions of ivermectin by healthcare providers have increased > tenfold from 3589 per week pre-COVID-19 to 39,102. Ivermectin is FDA approv...
Autores principales: | Molnar, Andreea, Lau, Stephanie, Berges, Maja, Masa, Raymond B., Solano, Joshua J., Alter, Scott M., Clayton, Lisa M., Shih, Richard D., DeMets, David L., Maki, Dennis G., Hennekens, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086156/ https://www.ncbi.nlm.nih.gov/pubmed/35147927 http://dx.doi.org/10.1007/s43441-022-00378-0 |
Ejemplares similares
-
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions
por: Shih, Richard D., et al.
Publicado: (2020) -
Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022) -
Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
por: Berges, Maja, et al.
Publicado: (2022) -
Genomic surveillance to combat COVID-19: challenges and opportunities
por: Robishaw, Janet D, et al.
Publicado: (2021) -
Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
por: D'andrea, Luca, et al.
Publicado: (2022)